Patients with Parkinson’s Disease Use CBD to Effectively Treat Condition
Posted by Marijuana Doctors on 11/22/2016 in Medical Marijuana Studies
Parkinson’s Disease is a disorder that comes about when neurons in certain areas of the nervous system fail to release enough dopamine, causing tremors, muscle rigidity, poor balance and slow movement. Sleep disturbance, neuropathy pain and mood changes are also a major part of symptoms. It is estimated that 1.5 million people in the United States alone suffer from this disorder. Walking, talking and other normally easy tasks are often difficult for those with Parkinson’s. With the success of using medical cannabis for other neurodegenerative disorders, the scientific community has begun to study medical marijuana effects on this disorder, which gets worse over time.
A Common Factor
Inflammation seems to be the one factor that is present in all neurodegenerative disorders, including Parkinson’s. It is believed this constant inflammation is what causes the disorder to get worse over time as it continues working to disable the cells that produce serotonin. The anti-inflammatory properties of CBD, as well as its neuroprotective properties, have interested researchers in its use to help slow down the progression of the disorder and control much of the pain suffered by those with the disorder.
Israel has recently undergone small-scale studies that have shown great promise. In one study of 20 participants, symptoms were measured at the beginning of the session and again thirty minutes after inhaling marijuana. The study was measuring the effects of medical marijuana on pain, tremors and muscle rigidity. All patients had been diagnosed for at least seven years and were of the average age of 66. All the participants were rated using the Unified Parkinson’s Disease Rating Scale (UPDRS). The effects on rigidity, tremors and bradykinesia showed a significant decrease in all cases. In addition, twelve of the patients mentioned sleeping better and the other eight said they slept slightly better. The average length of relief was two to three hours. This study was small, but if these results can be repeated on a larger scale, many of the medications now utilized for the control of Parkinson’s may be able to be reduced or replaced by cannabis. The fact that sleep is enhanced is a benefit because the body can heal better when asleep and Parkinson sufferers often find sleep difficult because of the pain and involuntary muscle movements.
What is Needed
We now know that marijuana benefits include antioxidant effects, anti-inflammatory properties, pain control and control for nausea and sleep problems. All of these are found in Parkinson’s Disease. What we need now is more opportunity to study the effects over a longer period of time and with a larger study group. Until that time, however, the ability of cannabis to ease many of the emotional issues of sufferers, including depression and sleep disorders, is well-documented. That alone should make it possible to help those with Parkinson’s realize some of the other, less researched benefits for now. By issuing marijuana cards for the relief of the documented symptoms, we would have a readily available research group that could help determine the extent of the benefits on other symptoms, as well as whether the initial belief that marijuana may slow the progression of Parkinson’s. As the focus of the scientific community moves towards less-researched disorders, Parkinson’s will gain greater attention.
Your Chance to Help
One of the main arguments about removing marijuana from the controlled substance list and having it classified as a medication has been the lack of wide-spread studies. Marijuana Doctors has taken steps to help eliminate that argument by embarking on the first nationwide study of cannabis card holders and doctors who can prescribe marijuana for medicinal purposes. Participants have access to an online symptom tracker that not only allows them a convenient place to track their progress but also allows their physician to track their progress in real-time. If you would like to be part of this important study, sign up today.